Sarepta Therap

Forecast & Rating23 analysts currently cover Sarepta Therap, with about 30.4% giving a positive rating — meaning they expect the stock to rise. The average price target is $22.17, about 45.8% upside from the current price of $15.21. Price targets range from $5.00 to $38.00 — a wide spread, showing clear disagreement over just how much Sarepta Therap can rise. Historically, about 64.1% of past price targets were eventually met, which adds credibility. For you, this means most institutions are cautious on Sarepta Therap's outlook. Data as of Jul 28, 2026; for reference only and not investment advice.